ISEE IVERIC bio Inc

Price (delayed)

$6.29

Market cap

$567.7M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.15

Enterprise value

$538.48M

Highlights
The debt has dropped by 67% year-on-year and by 8% since the previous quarter
ISEE's EPS is up by 16% year-on-year
The equity has soared by 60% YoY but it has decreased by 13% from the previous quarter
IVERIC bio's quick ratio has decreased by 9% YoY but it has increased by 7% from the previous quarter
IVERIC bio's net income has plunged by 57% YoY and by 14% from the previous quarter

Key stats

What are the main financial stats of ISEE
Market
Shares outstanding
90.26M
Market cap
$567.7M
Enterprise value
$538.48M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.39
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$96.65M
EBITDA
-$96.53M
Free cash flow
-$78.03M
Per share
EPS
-$1.15
Free cash flow per share
-$0.84
Book value per share
$1.85
Revenue per share
$0
TBVPS
$2.01
Balance sheet
Total assets
$187.4M
Total liabilities
$20.21M
Debt
$106,000
Equity
$167.19M
Working capital
$167.11M
Liquidity
Debt to equity
0
Current ratio
9.29
Quick ratio
8.94
Net debt/EBITDA
0.3
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-43.3%
Return on equity
-47.5%
Return on invested capital
-111.1%
Return on capital employed
-57.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ISEE stock price

How has the IVERIC bio stock price performed over time
Intraday
-3.82%
1 week
-5.56%
1 month
-1.26%
1 year
67.73%
YTD
-8.97%
QTD
1.78%

Financial performance

How have IVERIC bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$96.86M
Net income
-$96.27M
Gross margin
N/A
Net margin
N/A
IVERIC bio's net income has plunged by 57% YoY and by 14% from the previous quarter
The operating income is down by 45% YoY and by 9% from the previous quarter

Growth

What is IVERIC bio's growth rate over time

Valuation

What is IVERIC bio stock price valuation
P/E
N/A
P/B
3.39
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ISEE's EPS is up by 16% year-on-year
The stock's price to book (P/B) is 68% less than its 5-year quarterly average of 10.7 but 36% more than its last 4 quarters average of 2.5
The equity has soared by 60% YoY but it has decreased by 13% from the previous quarter

Efficiency

How efficient is IVERIC bio business performance
The ROIC has grown by 35% since the previous quarter
ISEE's return on equity is up by 20% year-on-year but it is down by 5% since the previous quarter
ISEE's return on assets is up by 19% year-on-year but it is down by 4.6% since the previous quarter

Dividends

What is ISEE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ISEE.

Financial health

How did IVERIC bio financials performed over time
IVERIC bio's total liabilities has surged by 82% YoY but it has decreased by 20% QoQ
The total assets has surged by 62% year-on-year but it has declined by 14% since the previous quarter
The debt is 100% smaller than the equity
The debt has dropped by 67% year-on-year and by 8% since the previous quarter
The equity has soared by 60% YoY but it has decreased by 13% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.